Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends
XTalks
AUGUST 2, 2023
2) Darzalex (daratumumab) Darzalex is a targeted monoclonal antibody that slows or stops the progression of multiple myeloma (a blood cancer) by binding to the CD38 protein on multiple myeloma cells. But all three drugs have new competitors. The list price of Stelara was stated to be $25,497.12 billion in 2022, a 32.44 billion in 2021.
98 
Let's personalize your content